[1] [3] A 2024 review by the European Medicines Agency (EMA) and MHRA concluded that available evidence does not support a causal association between GLP-1 receptor agonists (including semaglutide) and suicidal thoughts or behaviour
One of the key differences often highlighted is that tirzepatide works as a dual agonist , while semaglutide works as a single hormone agonist
Subgroup analyses Subgroup analyses of each GLP-1RA with multiple doses Among the 15 GLP-1RAs, 11 involved multiple doses in the included trials
Nevertheless, we arrived at similar results when the per-protocol analysis was applied, despite half of the patients in each group not being included in the analyses
To achieve optimal results, it is essential to combine semaglutide treatment with lifestyle modifications, such as adopting a balanced diet, engaging in regular physical activity, and developing healthy coping mechanisms for stress and emotional eating
Why IV delivery makes the difference: Your digestive system limits how much vitamin C you can absorb orally